Antibiotic resistance pattern of group-A beta-hemolytic streptococci isolated from north Indian children

Indian Journal of Medical Sciences

Volumn 62, Issue 10, 2008, Pages 392-396

  Jain, Amita ^a   Shukla, Vivek ^a   Tiwari, Vandana ^a   Kumar, Rashmi ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Group A beta hemolytic streptococci; Pharyngo tonsillitis; Streptococcus hemolyticus

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; COTRIMOXAZOLE; MACROLIDE; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DISK DIFFUSION; FEMALE; HUMAN; INDIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PEDIATRIC WARD; PHARYNGITIS; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; STREPTOCOCCUS GROUP A; THROAT CULTURE; TONSILLITIS;

CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PYOGENES; TONSILLITIS;

EID: 57149104112     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.44018     Document Type: Article

References (17)

1. American Academy of Pediatrics. Group-A streptococcal infection. In Redbook: Report of the committee on Infectious Diseases. vol. 3. Elk Grove Village: American Academy of Pediatrics; 2003. p. 526-36.
2. Bruton S, Pichichero. Consideration in the use of antibiotics for streptococcal pharyngitis. J Fam Pract 2006;supply:S9-16.
3. Clinical laboratory standard institute. Performance standards for antimicrobial disk susceptibility tests: Approved standard M17-A20. Wayne, PA. USA: Committee for clinical Laboratory Standards; 2005.
4. Cornaglia G, Ligozzi M, Mazzariol A, Valentini M, Orefici G, Fontana R, et al. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy 1993-1995. Emerg Infect Dis 1996;2:339-42.
5. Dohar JE. Management of group A beta-hemolytic streptococcal pharyngotonsillitis in children. J Fam Pract Book I 2006;55:S1-11.
6. Gerber MA. Antibiotic resistance: Relationships to persistence of group A streptococci in the upper respiratory tract. Pediatrics 1996;97:971-5.
7. Johnson DR, Kaplan EL. Laboratory diagnosis of group A Streptococcal infections. Geneva: WHO; 1996.
8. Kaya EG, Yucel M, Karakoc AE. Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci. Mikrobiyol Bul 2006;40:161-8.
9. Lloyd CA, Jacob SE, Menon T. Antibiotic resistant beta-hemolytic streptococci. Indian J Pediatr 2007;74:1077-88.
10. Lowbury EJ, Cason JS. Aureomycin and erythromycin therapy for Streptococcus pyogenes in burns. Br Med J 1954;2:914-5.
11. Linder JA, Bates DW, Lee GM. Antibiotic treatment of children with sore throat. JAMA 2005;294:2354-6.
12. Mariani-Kurkdjian P, Doit C, Deforche D, Brahimi N, Francois M, Francois M, et al. Current Streptococcus pyogenes sensitivity responsible for acute tonsillopharyngitis in France. Press Med 2004;33:703-6.
13. Rajesh KR, Gordon RC. Streptococcal pharyngitis: Is penicillin still the drug of choice? Indian J Pediatr 1996;63:437-40.
14. Senses Z, Baysallar M, Gur D, Doganci L. Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002. Mikrobiyol Bul 2003;37:225-34.
15. Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, et al. Resistance to erythromycin in group-A streptococci. N Engl J Med 1992;326:292-7.
16. Vollater MM, Soriano NJ, Salvert LM. Group A streptococcal bacteremia outcome and prognostic factors. Rev Esp Quimioter 2006;19:367-75.
17. Yazgi H, Ertek M, Aktaş AE; Erythromycin resistance of group. A beta-hemolytic streptococci isolated from patients with upper respiratory tract infections. Mikrobiyol Bul 2002;36:11-4.